UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005503 |
|---|---|
| Receipt number | R000006524 |
| Scientific Title | First-line trial of CBDCA + S-1 + Gefitinib for patients with advanced or reccurent NSCLC patients harboring activating mutation of the EGFR gene -Phase II trial- |
| Date of disclosure of the study information | 2011/05/01 |
| Last modified on | 2017/08/13 09:01:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/04/25 15:45:29 | ||
| 2 | Update | 2011/08/07 09:13:26 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2011/10/26 08:02:09 | Email |
|
| 4 | Update | 2013/04/25 10:38:28 | Recruitment status |
|
| 5 | Update | 2014/05/01 11:51:31 | Email |
|
| 6 | Update | 2014/10/26 12:23:38 | Key inclusion criteria |
|
| 7 | Update | 2014/11/25 19:57:55 | Publication of results |
|
| 8 | Update | 2015/04/27 19:47:40 | Recruitment status |
|
| 9 | Update | 2017/08/13 08:59:01 | Name of primary person or sponsor Organization |
|
| 10 | Update | 2017/08/13 09:01:05 | Date analysis concluded |
